Please JOIN US on Tuesday July 12 at 2000EDT: CAR T-Cell Therapy
Posted over 2 years ago by Camille Dyer
CAR T-cell Therapy:
The PA’s Role in Identifying Candidates & Treating Patients
TUESDAY, JULY 12, 2022
8:00pm ET
Live, virtual activity
CLICK HERE TO REGISTER FOR THE PROGRAM
Or copy and paste the following link into your browser:
https://us02web.zoom.us/meeting/register/tZMvc-CupzoqHdAsY2V8AhdoyQrpy3oyhc0N
After registering, you will receive a confirmation email containing information about joining the meeting.
Speakers
Theresa Elko, MPAS, PA-C
Clinical Research PA, Adult Bone Marrow Transplant Service
Memorial Sloan Kettering Cancer Center
New York, NY
Lauren Levy, MPAS, PA-C
Clinical Research PA, Adult Bone Marrow Transplant Service
Memorial Sloan Kettering Cancer Center
New York, NY
Learning Objectives: After completing this CE activity, the participant should be better able to:
- Explain the role and clinical action of CAR T-cell therapy as a treatment option for hematologic malignancies
- Explain the benefits and risks of CAR T-cell therapy
- Identify current approved CAR T-cell therapies for blood cancer as well as emerging data for other cancers
- Identify potential candidates for referral to a CAR T treatment center for therapy evaluation
- Describe barriers to access and resources for support
Continuing Education (CE) Information
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 6/29/2022 to 6/29/2024. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-206402.